 Gruppe A: 0,033mg WH/kg x die  Gruppe B: 0,067mg WH/kg x die

Slides:

Advertisements

Similar presentations

Newly diagnosed hypertensive patients with type 2 diabetes (n = 1544) Randomisation Avoid ACE inhibitors/ beta-blockers (n = 390) Tight BP control (n =

Advertisements

* Plus–minus values are means ±SD. † Race was determined by the investigator. ‡ The body-mass index is the weight in kilograms divided by the square of.

Women and Cholesterol What You Need to Know. Age: 45 Women and Cholesterol: What You Need to Know HDL: 60 mg/dL and above LDL: Below 100 mg/dL GoodBad.

CHAPTER 13 RENAL TRANSPLANTATION Editor: Dr. Goh Bak Leong Expert Panel: Dato’ Dr. Zaki Morad b Mohd Zaher (Chair) Dr. Goh Bak Leong (Co-Chair) Dr. Fan.

Table 5.1.1: Stock and Flow of Renal Transplantation, Year New transplant patients

CHAPTER 5 RENAL TRANSPLANTATION Editor: Dr. Goh Bak Leong Expert Panel: Dato’ Dr. Zaki Morad b Mohd Zaher (Chair) Dr. Goh Bak Leong (Co-Chair) Dr. Fan.

Consensus procedure for the management of children with ESRD.

CHAPTER 13 Renal Transplantation Goh Bak Leong Fan Kin Sing Rohan Malek Bin Dato’ Dr. Johan Rosnawati Yahya S. Prasad Menon Tan Si Yen Wong Hin Seng Source:

骨质疏松症厦门長庚醫院骨科吴轲衛教講座. 什么是骨质疏松症一种全身性骨量降低，使骨骼微细结构发生破坏的疾病，会导致骨骼的脆弱，结果使发生骨折的危险性增加。英文字义 = 多孔的骨骼.

Parameters BD PP CP TC (mg. dl-l) ± * ± 5.8

analysed to establish the distribution of GJD2 SNPs T2D patients

Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes: a population-level cohort study Dr Jack R W Brownrigg,

Features of adult GH deficiency Improved by GH replacement?

Adverse Events - Demographics

Copyright © 2010 American Medical Association. All rights reserved.

0.24→0.37 mg/kg/week (▲) and 0.37 mg/kg/week ().

Raw data Log-transformed data Male age log age Female age log age

Supplemental Figure 1 A B C D E F

*Imperial College London

ERT, estrogen replacement therapy

Fig. 1. Mean BMI and BMI Z-score (se) of the children with AA, TA, and TT genotypes in rs of the FTO gene. The P values are for the additive model.

Adding rosiglitazone to metformin in patients with type 2 diabetes: Effect on diabetes control and metabolic parameters Hussein Raef, Abdulraof Al-Mahfouz,

by Sarah Steinmetz and Amber Brouillette

(B.P :51) ( B:P52 ).

Sunjoo Boo, RN, PhD, Erika Sivarajan Froelicher, RN, PhD, FAAN

Cholesterol and blood pressure values at baseline and after 15 days of dark-chocolate and white-chocolate consumption Characteristic Dark chocolate before.

NCEP/Framingham risk scores: Estimate of 10-yr CHD risk in men without CHD VBWG Age (y) 20–34 35–39 40–44 45–49 50–54 55–59 60–64 65–69 70–74 75–79.

Volume 62, Issue 5, Pages (November 2002)

GH peak (µg/l) Regression analysis of the GHRH+GHRP-6-elicited GH peaks plotted against body mass index (BMI), in 366 subjects with no endocrine pathology.

Sunjoo Boo, RN, PhD, Erika Sivarajan Froelicher, RN, PhD, FAAN

Major physical anomalies according to parental origin of retained Xp

#significant difference versus baseline (P<.05).

Effects of 5 yr of GH substitution in 118 GH-deficient adults on serum concentrations of TC, HDL-C, LDL-C and TG as well as on blood glucose, serum insulin.

A B D C Total adiponectin (μg/ml ) Hb ( g / dl ) r = p = 0.003

Relationship between karyotype and basal characteristics at GH start

The prevalence of Recurrent Stroke and TIA and the related factors

Fig.1. The dose of GH administered to patients in different age groups after 1 year of GH replacement therapy. Data are shown as mean, median and 10th-90th.

Controls r=-0.82; P< GHD r=-0.84; P< Mean IMT (mm)

Control Subjects MPHD Patients Control Subjects MPHD Patients

No GH (n=19) Treated with GH (n=67) Mean (SD) Range Mean (SD) Range

GH dose 12 months of treatment 24 months of treatment Low Medium High

Fig.1 Simple least-squares regression of the relationship between the log of peak GH concentration on standard GH stimulation tests and serum IGF-1 concentrations.

 Height SDS  Weight SDS

Phenotypes in shox haploinsufficiency

Height velocity (cm/yr) Height velocity (cm/yr)

S. So¨derstro¨m, G. Nyberg, M.F. O’Rourke, J. Sellgren, J. Pontén

STAI: higher scores reflect more anxiety (scores 20-80).

Ongoing statin therapy at hospitalization for acute myocardial infarction. Learnings for general practitioners. Ghena Shabana Specialist in Family Medicine.

Going round in circles… Going round in circles…

Sensivity Sensivity Sensivity 100-specify 100-specify 100-specify

Comparison between groups

Baseline Characteristics of the Subjects*

Growth rate (cm/yr) Estrogen at age 12 Estrogen at age 15

(A) Low-density lipoprotein-cholesterol (LDL-C) values at baseline and after treatment with anagliptin in 20 participants at 12 and 24 weeks. (A) Low-density.

The Healthy Beverage Index Is Associated with Reduced Cardio-metabolic Risk in US Adults: A Preliminary Analysis Kiyah J. Duffey, PhD Brenda M. Davy, PhD,

Abbildung mod. nach Van Pareren, 2004

RECORD Study: Enrollment and Outcomes

Change in LBM (%)‏ LD CD LD CD LD CD

VK2809 in NAFLD: a phase 2 study

Receiver operating curves (ROC) of simple age and gender adjusted risk factor models for predicting 10-year risk of cardiovascular disease comparing the.

Lars E. Laugsand et al. BTS 2016;j.jacbts

Intensive Lowering of Low-Density Lipoprotein Cholesterol Levels for Primary Prevention of Coronary Artery Disease Dean G. Karalis, MD Mayo Clinic Proceedings

III. Treating dyslipidemias

diabetic rats treated with BPHs

Insert Case Title Case Overview

Mean adjusted levels in each group for the following cardiometabolic risk factors at 3 and 12 months postpartum: (A) systolic blood pressure, (B) diastolic.

Table I Male Disc Participants: Mean (S.D.)

Changes of major clinical and biochemical characteristics at baseline and during follow-up in different groups. Changes of major clinical and biochemical.

Presentation transcript:

 Gruppe A: 0,033mg WH/kg x die  Gruppe B: 0,067mg WH/kg x die BMI SD-score Skinfold SD-score yr of GH treatment yr of GH treatment Mean (SD) BMI SD-score before and during 6 yr of GH treatment for group A () and for group B () Mean (SD) Skinfold SD-score before and during 6 yr of GH treatment for group A () and for group B () Abbildung mod. nach Sas, 2000

systolic BP SD-score systolic BP SD-score  Gruppe A: 0,033mg WH/kg x die  Gruppe B: 0,067mg WH/kg x die BPage BPheight BPage BPheight systolic BP SD-score systolic BP SD-score yr of GH treatment yr of GH treatment Mean (SD) systolic BP SD-socre (left) and diastolic BP SD-score (right), using age-matched reference values (BPage), before and during 6 yr of GH treatment for group A () and for group B (). On the right part of each panel is the BP SD-score using height matched reference values (BPheight) before and after 6 yr of GH treatment Abbildung mod. nach Sas, 2000

Cholesterol TC Mean (SD) levels of TC (squares), LDL cholesterol (triangles), and HDL cholesterol (circles) before and during 4 yr of GH treatment for group A (filled symbols) and group B (open symbols) mmol/l LDL HDL yr of GH treatment Abbildung mod. nach Sas, 2000